Weekly Digest – May 2025 Weekly Digest – May 2025 19 May 2025: Blenrep (Belantamab mafodotin) combinations approved in Japan for treatment of relapsed/refractory multiple Myeloma GSK’s Blenrep in combination with bortezomib plus dexamethasone (BVd) and in combination with pomalidomide […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id